Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, March 09, 2011

abstract: A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: (GOG 146Q)

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.